MACROGENICS INC

By person

23 insiders · 131 transactions

0.5×

Eric Risser holds only 0.5 times base salary in stock. $320.25K of shares against $561.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Eric Risser last reported holding, valued at $4.15, the price Common Stock was last bought or sold at on the open market here, on 19 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BIOTECH TARGET N V

10% owner

$38.60M (19)

—

+$38.60M

9,929,963

15.59%

$41.21M

+64.8%

Peters Jeffrey Stuart

Senior VP, GC, and Secretary

—

$3.50M (14) scheduled

−$3.50M

0.0000%

$0.00

−100.0%

Bonvini Ezio

Sr VP, Research & CSO

—

$2.65M (7)

−$2.65M

185,799

0.2917%

$771.07K

+111.0%

Risser Eric Blasius

President and CEO

—

$1.63M (26) scheduled

−$1.63M

77,169

0.1211%

$320.25K

+985.5%

Karrels James

SVP and CFO

$98.80K (1)

$1.27M (3)

−$1.17M

206,037

0.3234%

$855.05K

+105.4%

Wigginton Jon Marc

Sr VP, Clinical Dev. & CMO

—

$1.09M (7) scheduled

−$1.09M

18,930

0.0297%

$78.56K

−36.9%

Spitznagel Thomas

Sr VP, Technical Ops

—

$923.98K (6) scheduled

−$923.98K

38,543

0.0605%

$159.95K

—

Cilinski Lynn

VP, Controller and Treasurer

—

$781.88K (2) scheduled

−$781.88K

6,213

0.0098%

$25.78K

+223.1%

Galbraith Kenneth

Director

—

$563.16K (2) scheduled

−$563.16K

0.0000%

$0.00

—

Fust Matthew K

Director

—

$203.43K (1) scheduled

−$203.43K

500

0.0008%

$2.08K

0.0%

HEIDEN WILLIAM K

Director

$150.52K (2)

—

+$150.52K

114,750

0.1801%

$476.21K

—

HURWITZ EDWARD

Director

$73.65K (1)

—

+$73.65K

47,824

0.0751%

$198.47K

+164.6%

Smith Beth Ann

VP, Controller & Treasurer

—

$1.08K (1) scheduled

−$1.08K

12,781

0.0201%

$53.04K

+62.0%

Koenig Scott

Director

—

2,165,915

3.40%

$8.99M

+33.1%

Eck Stephen L.

Chief Medical Officer

—

29,377

0.0461%

$121.91K

—

SARAN ATUL

SVP & General Counsel

—

16,986

0.0267%

$70.49K

−9.9%

Ferrante Karen Jean

Director

—

14,750

0.0232%

$61.21K

—

STUMP DAVID C

Director

—

14,750

0.0232%

$61.21K

—

O'Brien Federica F.

Director

—

14,750

0.0232%

$61.21K

—

Jackson Scott Thomas

Director

—

14,750

0.0232%

$61.21K

—

SIEGEL JAY PHILIP

Director

—

14,750

0.0232%

$61.21K

—

Liu Margaret

Director

—

14,750

0.0232%

$61.21K

—

Chhabra Meenu

Director

—

14,750

0.0232%

$61.21K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Peters Jeffrey Stuart

19 Aug 2026

Senior VP, GC, and Secretary

Sold on a plan

31,105

$4.15

$129.09K

Karrels James

4 Mar 2024

SVP, CFO and Secretary

Sold on a plan

30,000

$20.50

$615.00K

Peters Jeffrey Stuart

26 Feb 2024

Senior VP and General Counsel

Sold on a plan

16,124

$17.22

$277.66K

Bonvini Ezio

7 Feb 2024

Sr VP, Research & CSO

Sold on a plan

3,334

$18.00

$60.01K

Bonvini Ezio

1 Feb 2024

Sr VP, Research & CSO

Sold on a plan

13,316

$15.00

$199.74K

Bonvini Ezio

19 Jan 2024

Sr VP, Research & CSO

Sold on a plan

13,316

$12.00

$159.79K

Bonvini Ezio

20 Dec 2023

Sr VP, Research & CSO

Sold on a plan

18,880

$10.08

$190.31K

Show all 131 transactions →

By person

Individual transactions

What was left out